Echo45 Advisors LLC Eli Lilly & CO Transaction History

Echo45 Advisors LLC

$144 Million
Q3 2024

A detailed history of Echo45 Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Echo45 Advisors LLC holds 521 shares of LLY stock, worth $414,544. This represents 0.32% of its overall portfolio holdings.

Number of Shares

521

Previous 569 8.44%

Holding current value

$414,544

Previous $515,000 10.49%

% of portfolio

0.32%

Previous 0.39%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	SELL	$772.14 - $960.02 $37,062 - $46,080	-48 Reduced 8.44%	521 $461,000
Q2 2024 Jul 26, 2024	SELL	$724.87 - $909.04 $59,439 - $74,541	-82 Reduced 12.6%	569 $515,000
Q1 2024 Apr 18, 2024	SELL	$592.2 - $792.28 $4,145 - $5,545	-7 Reduced 1.06%	651 $506,000
Q4 2023 Jan 31, 2024	BUY	$525.19 - $619.13 $12,604 - $14,859	24 Added 3.79%	658 $383,000
Q3 2023 Nov 02, 2023	SELL	$434.7 - $599.3 $24,777 - $34,160	-57 Reduced 8.25%	634 $340,000
Q2 2023 Jul 31, 2023	SELL	$350.74 - $468.98 $21,745 - $29,076	-62 Reduced 8.23%	691 $324,000
Q1 2023 Apr 26, 2023	SELL	$310.63 - $364.82 $18,016 - $21,159	-58 Reduced 7.15%	753 $258,000
Q4 2022 Jan 30, 2023	BUY	$321.55 - $374.67 $21,543 - $25,102	67 Added 9.01%	811 $296,000
Q3 2022 Oct 18, 2022	SELL	$296.48 - $337.87 $2,668 - $3,040	-9 Reduced 1.2%	744 $241,000
Q2 2022 Jul 27, 2022	SELL	$278.73 - $327.27 $11,427 - $13,418	-41 Reduced 5.16%	753 $244,000
Q1 2022 Apr 29, 2022	SELL	$234.69 - $291.66 $28,632 - $35,582	-122 Reduced 13.32%	794 $227,000
Q4 2021 Feb 28, 2022	BUY	$224.85 - $279.04 $205,962 - $255,600	916 New	916 $253,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Echo45 Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Echo45 Advisors LLC with notifications on news.

Account

Echo45 Advisors LLC Eli Lilly & CO Transaction History